Mood, Sleep, and Appetite

How 5-HTP, the direct precursor to serotonin, supports mood, sleep quality, and appetite regulation

5-HTP (5-hydroxytryptophan) is a naturally occurring amino acid your body makes on the way to producing serotonin — the neurotransmitter most associated with mood, sleep, and appetite control. Unlike tryptophan (found in turkey and nuts), 5-HTP crosses the blood-brain barrier efficiently and bypasses the rate-limiting step in serotonin production [5]. It is derived commercially from the seeds of Griffonia simplicifolia, a West African plant, and has been studied in clinical trials for depression, insomnia, and weight management since the 1970s. The evidence is strongest for mood support, with clinical trials showing results comparable to antidepressants in some populations [1][2].

How 5-HTP Works

Your brain produces serotonin in two steps: dietary tryptophan is first converted to 5-HTP by an enzyme called tryptophan hydroxylase, and then 5-HTP is converted to serotonin by another enzyme, aromatic amino acid decarboxylase. The first step is the bottleneck — tryptophan hydroxylase is easily saturated and competes with other amino acids for transport across the blood-brain barrier.

5-HTP sidesteps this problem entirely. It enters the brain directly and efficiently (approximately 70% oral bioavailability), where it is rapidly converted to serotonin [5][6]. Because it doesn't compete with other amino acids for transport, it works whether or not you've eaten protein — unlike tryptophan supplements.

Serotonin itself doesn't cross the blood-brain barrier, so raising serotonin by taking 5-HTP (which works inside the brain) is fundamentally different from raising peripheral serotonin through food.

Mood Support

The most studied use of 5-HTP is for depression. A 2020 systematic review and meta-analysis covering 13 investigations found a depression remission rate of 65% and a large effect size (Hedges' g = 1.11) [1]. A double-blind RCT directly comparing 5-HTP to fluoxetine (Prozac) in 60 patients with first-episode depression found both produced nearly identical improvements on the Hamilton Depression Rating Scale, with response rates of 73% versus 80% respectively [2]. The authors concluded that 5-HTP had "definitely got antidepressant effect equal to that of fluoxetine."

That said, most clinical trials in this area are small, and the Cochrane review notes that only 2 trials in their analysis met quality criteria — the evidence is positive but calls for more rigorous studies [1].

Typical doses studied: 50–300 mg/day, often split into two doses.

Sleep Quality

5-HTP supports sleep by increasing serotonin, which the brain's pineal gland uses to make melatonin during darkness. A 2024 randomized controlled trial in older adults (100 mg/day for 12 weeks) found that poor sleepers experienced significant improvements in the Global Sleep Score and reduced sleep latency by the end of the trial [3]. Serum serotonin increased, and gut microbiota diversity improved — particularly bacteria that produce short-chain fatty acids, pointing to a gut-brain axis connection.

Taking 5-HTP in the evening (20–30 minutes before bed) is the most common approach for sleep support. Combining it with B6 may enhance conversion to serotonin, though the additional benefit is not well established in trials.

Appetite and Weight

5-HTP reliably reduces carbohydrate intake and increases the feeling of early satiety. A landmark double-blind crossover trial found that obese adults taking 900 mg/day lost significant weight even without being instructed to diet, primarily by reducing spontaneous carbohydrate consumption [4]. A more recent 8-week RCT (100 mg/day) found significant fat mass reduction versus placebo without changes in dietary intake, suggesting metabolic effects beyond simple calorie reduction [4].

The mechanism appears to be serotonergic signaling in the hypothalamus, which modulates hunger and meal termination.

Dosing and Considerations

Depression/mood: 100–300 mg/day, often divided doses
Sleep: 50–100 mg taken 30–60 minutes before bed
Appetite: 100–300 mg before meals

5-HTP should not be combined with SSRIs, SNRIs, MAOIs, or other serotonergic medications without medical supervision — the combination can theoretically cause serotonin syndrome, a serious condition involving excessive serotonin activity [6]. This is not a supplement to take casually alongside antidepressant medications.

Some people experience GI side effects (nausea, diarrhea) at higher doses; starting low and increasing gradually helps. Taking it with a small amount of food can reduce nausea.

See our magnesium page for another evidence-based approach to sleep, and our l-theanine page for anxiety support without drowsiness.

Evidence Review

Depression

The most comprehensive evidence comes from a 2020 systematic review and meta-analysis (Javelle et al., Nutrition Reviews) covering 13 investigations, 7 of which were included in a quantitative meta-analysis [1]. The pooled remission rate was 65% (95% CI: 55–78%), with a large effect size (Hedges' g = 1.11, 95% CI: 0.53–1.69). The authors noted substantial heterogeneity across studies and called for better-designed trials.

The 2013 RCT by Jangid et al. (Asian Journal of Psychiatry, n=60) is one of the cleaner head-to-head comparisons: a double-blind 8-week trial randomized first-episode depressed patients to either 5-HTP or fluoxetine 20 mg/day [2]. HAM-D scores declined significantly and nearly identically in both groups beginning at week 2. Response rates were 73.3% (5-HTP) vs. 80% (fluoxetine) — a non-significant difference. This is notable given that 5-HTP lacks the regulatory support and multi-billion-dollar development investment behind SSRIs.

The Cochrane review (Shaw et al., 2002) is more cautious: of 108 identified trials, only 2 met quality criteria (n=64 combined) [1]. Those trials did favor 5-HTP over placebo (Peto OR 4.10, 95% CI: 1.28–13.15), but the reviewers concluded evidence is insufficient for definitive recommendations given trial quality concerns, including risk of bias and small sample sizes.

Sleep

The most rigorous sleep data comes from a 2024 Singapore RCT (Sutanto et al., Clinical Nutrition, n=30, mean age 66) using 100 mg/day for 12 weeks [3]. In the subgroup of poor sleepers (PSQI score ≥5), the Global Sleep Score improved significantly by week 12, with reduced sleep latency. Serum serotonin levels rose significantly in the active group. Gut microbiota analysis found increased abundance of SCFA-producing genera, suggesting an effect on the gut-brain axis that may mediate some sleep benefits.

Earlier mechanistic work (Nakazawa et al., 1980) showed that 200 mg oral 5-HTP altered sleep architecture — decreasing Stage 1, increasing Stage 2, and increasing REM sleep — though the significance of these architectural changes for sleep quality is unclear.

Appetite and Weight Management

Cangiano et al. (American Journal of Clinical Nutrition, 1992) conducted a double-blind crossover trial in 20 obese adults, each completing two 6-week periods (with and without dietary advice) while taking 900 mg/day 5-HTP or placebo [4]. In both periods, 5-HTP produced significantly greater weight loss than placebo. Carbohydrate intake decreased substantially, and subjects consistently reported early satiety. This was an unusually robust design for the era.

A 2022 RCT (Evans et al., Journal of Dietary Supplements, n=48, 8 weeks, 100 mg/day) found that fat mass decreased significantly in the 5-HTP group (p=0.02) while the placebo group did not change, with a significant between-group difference (p=0.048) [4]. Lean mass and self-reported dietary intake did not differ significantly, making a simple appetite-suppression explanation insufficient.

Safety

The safety profile of 5-HTP is generally favorable in short-term trials. A comprehensive 2004 review (Das et al., Toxicology Letters) found no confirmed cases of eosinophilia-myalgia syndrome (EMS) — the condition that led to tryptophan being pulled from sale in 1989 — in over 20 years of 5-HTP use worldwide [7]. Unlike the tryptophan EMS outbreak (which was traced to a specific contaminated batch from one manufacturer), 5-HTP has not been implicated in similar events. The review identified a chromatographic peak sometimes found in 5-HTP products but attributed it to an artifact at negligible concentrations.

The primary safety concern is serotonin syndrome when combined with serotonergic drugs (SSRIs, MAOIs, triptans, tramadol). GI side effects are the most common complaint in trials, dose-dependent and manageable by starting at 50 mg and increasing gradually.

Long-term use beyond 12 weeks is poorly studied. Based on the available evidence, 5-HTP appears to be a moderately effective and well-tolerated option for mood, sleep, and appetite support — with the important caveat that it should not be combined with prescription serotonergic medications.

References

Effects of 5-hydroxytryptophan on distinct types of depression: a systematic review and meta-analysisJavelle F, Lampit A, Bherer L, Maere S, Johnson SL, Bhattacharya K. Nutrition Reviews, 2020. PubMed 31504850 →
Comparative study of efficacy of l-5-hydroxytryptophan and fluoxetine in patients presenting with first depressive episodeJangid P, Malik P, Singh P, Sharma M, Gulia AK. Asian Journal of Psychiatry, 2013. PubMed 23380314 →
The impact of 5-hydroxytryptophan supplementation on sleep quality and gut microbiota composition in older adults: a randomized controlled trialSutanto CN, Xia X, Heng CW, Tan AYX, Kim JE. Clinical Nutrition, 2024. PubMed 38309227 →
Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophanCangiano C, Ceci F, Cascino A, Del Ben M, Laviano A, Muscaritoli M, Antonucci F, Rossi-Fanelli F. American Journal of Clinical Nutrition, 1992. PubMed 1384305 →
5-Hydroxytryptophan: a clinically-effective serotonin precursorBirdsall TC. Alternative Medicine Review, 1998. PubMed 9727088 →
Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophanTurner EH, Loftis JM, Blackwell AD. Pharmacology and Therapeutics, 2006. PubMed 16023217 →
Safety of 5-hydroxy-L-tryptophanDas YT, Bagchi M, Bagchi D, Preuss HG. Toxicology Letters, 2004. PubMed 15068828 →